Eyepoint Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $525k | 97k | 5.42 |
| 2024-12-31 | $673k | 90k | 7.45 |
| 2024-09-30 | $548k | 69k | 7.99 |
| 2024-06-30 | $689k | 79k | 8.70 |
| 2024-03-31 | $209k | 10k | 20.67 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas